| Literature DB >> 18471236 |
Agnès Kamoun-Goldrat1, Danielle Ginisty, Martine Le Merrer.
Abstract
Bisphosphonates are currently used in the therapy of osteogenesis imperfecta (OI) to decrease the bone fragility observed in OI patients. Bisphosphonate therapy delays tooth eruption in rats. The aim of this study was to determine whether or not bisphosphonate therapy delays tooth eruption in children. The clinical emergence of teeth was observed and the calculated dental age and the number of delayed teeth were determined for 33 OI patients treated with bisphosphonates and for strictly gender- and age-matched controls. There were significant differences between bisphosphonate-treated patients and controls for calculated dental age and number of delayed teeth. Bisphosphonate therapy was associated with a mean delay of 1.67 yr in tooth eruption in children with OI.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18471236 DOI: 10.1111/j.1600-0722.2008.00529.x
Source DB: PubMed Journal: Eur J Oral Sci ISSN: 0909-8836 Impact factor: 2.612